Disopyramide: Six Years' Experience-Reference-Cited by-同舟云学术

Disopyramide: Six Years' Experience

Published:1983-06 Issue:6 Volume:34 Page:367-374
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Wilson Richard R.¹,Wallace Andrew G.²

Affiliation:

1. Cardiovascular-Renal Clinical Research, G. D. Searle & Co., Skokie, Illinois

2. Duke Hospital, Duke University Medical Center, Durham, North Carolina

Abstract

Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias. During this time, clinical experience has refined our knowledge of this agent, allowing revision of dosing guidelines and better selection of patients. This review explores the recent therapeutic experience with disopyramide.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/000331978303400601

Reference50 articles.

1. Electrophysiological and clinical effects of a new antiarrhythmic agent: Disopyramide

2. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate

3. Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia

4. Electrophysiological evaluation of disopyramide in man

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disopyramide and N-Monodesalkyl Disopyramide in Serum and Breast Milk;DICP;1989-01

2. Long-term therapy with disopyramide phosphate: Side effects and effectiveness;American Heart Journal;1986-04

3. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage;International Journal of Cardiology;1985-12